XML 24 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Millions
Total
Elkay Manufacturing Company
Common Stock
Additional Paid-In Capital
Additional Paid-In Capital
Elkay Manufacturing Company
Retained (Deficit) Earnings
Accumulated Other Comprehensive (Loss) Income
Beginning balance at Dec. 31, 2022 $ 1,615.0   $ 1.8 $ 2,853.1   $ (1,164.9) $ (75.0)
Comprehensive income (loss):              
Net income 112.7         112.7  
Foreign currency translation and other adjustments 3.6           3.6
Change in pension and other postretirement benefit obligations, net of tax 3.7           3.7
Total comprehensive income 120.0         112.7 7.3
Stock-based compensation expense 41.6     41.6      
Proceeds from exercise of stock options and ESPP contributions 4.3     4.3      
Taxes withheld and paid on employees' share-based payment awards (3.1)     (3.1)      
Repurchase of common stock [1] (126.1)   (0.1)     (126.0)  
Elkay Merger [2]   $ (5.1)     $ (5.1)    
Common stock dividends (43.8)     (43.8)      
Ending balance at Dec. 31, 2023 1,602.8   1.7 2,847.0   (1,178.2) (67.7)
Comprehensive income (loss):              
Net income 160.2         160.2  
Foreign currency translation and other adjustments (10.0)           (10.0)
Change in pension and other postretirement benefit obligations, net of tax 3.3           3.3
Total comprehensive income 153.5         160.2 (6.7)
Stock-based compensation expense 37.9     37.9      
Proceeds from exercise of stock options and ESPP contributions 8.6     8.6      
Taxes withheld and paid on employees' share-based payment awards (8.6)     (8.6)      
Repurchase of common stock [1] (150.7)         (150.7)  
Common stock dividends (56.7)     (56.7)      
Ending balance at Dec. 31, 2024 1,586.8   1.7 2,828.2   (1,168.7) (74.4)
Comprehensive income (loss):              
Net income 198.0         198.0  
Foreign currency translation and other adjustments 4.9           4.9
Change in pension and other postretirement benefit obligations, net of tax (7.2)           (7.2)
Total comprehensive income 195.7         198.0 (2.3)
Stock-based compensation expense 40.6     40.6      
Proceeds from exercise of stock options and ESPP contributions 7.8     7.8      
Taxes withheld and paid on employees' share-based payment awards (0.6)     (0.6)      
Repurchase of common stock [1] (161.0)         (161.0)  
Common stock dividends (66.0)     (66.0)      
Ending balance at Dec. 31, 2025 $ 1,603.3   $ 1.7 $ 2,810.0   $ (1,131.7) $ (76.7)
[1] During the years ended December 31, 2025, 2024, and 2023, the Company repurchased and canceled 4.4 million shares, 4.7 million shares and 5.3 million shares of common stock at a total cost of $159.9 million, $150.2 million and $125.0 million at an average price of $36.74, $31.81 and $23.66 per share, respectively. For the years ended December 31, 2025, 2024, and 2023 the Company recognized $1.1 million, $0.5 million, and $1.0 million of excise tax on the repurchases, respectively. See Note 17, Common Stock Repurchases for additional information.
[2] Refer to "Item 8. Financial Statements and Supplementary Data, Note 3, Acquisitions" of our 2024 Form 10-K for additional information regarding the Elkay Merger.